{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:19:57Z","timestamp":1770992397121,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T00:00:00Z","timestamp":1346889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T00:00:00Z","timestamp":1346889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep00637","type":"journal-article","created":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T09:09:58Z","timestamp":1346922598000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Silencing of microRNA-122 enhances interferon-\u03b1 signaling in the liver through regulating SOCS3 promoter methylation"],"prefix":"10.1038","volume":"2","author":[{"given":"Takeshi","family":"Yoshikawa","sequence":"first","affiliation":[]},{"given":"Akemi","family":"Takata","sequence":"additional","affiliation":[]},{"given":"Motoyuki","family":"Otsuka","sequence":"additional","affiliation":[]},{"given":"Takahiro","family":"Kishikawa","sequence":"additional","affiliation":[]},{"given":"Kentaro","family":"Kojima","sequence":"additional","affiliation":[]},{"given":"Haruhiko","family":"Yoshida","sequence":"additional","affiliation":[]},{"given":"Kazuhiko","family":"Koike","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,9,6]]},"reference":[{"key":"BFsrep00637_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nrgastro.2011.49","volume":"8","author":"WP Hofmann","year":"2011","unstructured":"Hofmann, W. P. & Zeuzem, S. A new standard of care for the treatment of chronic HCV infection. Nat Rev Gastroenterol Hepatol 8, 257\u2013264 (2011).","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"BFsrep00637_CR2","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1056\/NEJMoa0707615","volume":"359","author":"AM Di Bisceglie","year":"2008","unstructured":"Di Bisceglie, A. M. et al. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med 359, 2429\u20132441 (2008).","journal-title":"N Engl J Med"},{"key":"BFsrep00637_CR3","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMe0901869","volume":"360","author":"JH Hoofnagle","year":"2009","unstructured":"Hoofnagle, J. H. A step forward in therapy for hepatitis C. N Engl J Med 360, 1899\u20131901 (2009).","journal-title":"N Engl J Med"},{"key":"BFsrep00637_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.immuni.2006.08.007","volume":"25","author":"DB Stetson","year":"2006","unstructured":"Stetson, D. B. & Medzhitov, R. Type I interferons in host defense. Immunity 25, 373\u2013381 (2006).","journal-title":"Immunity"},{"key":"BFsrep00637_CR5","doi-asserted-by":"crossref","unstructured":"Schindler, C. Teaching resources. Cytokine receptors and Jak-STAT signaling. Sci STKE 2006, (2006).","DOI":"10.1126\/stke.3382006tr7"},{"key":"BFsrep00637_CR6","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nri2093","volume":"7","author":"A Yoshimura","year":"2007","unstructured":"Yoshimura, A., Naka, T. & Kubo, M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7, 454\u2013465 (2007).","journal-title":"Nat Rev Immunol"},{"key":"BFsrep00637_CR7","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1128\/JVI.02583-10","volume":"85","author":"Y Funaoka","year":"2011","unstructured":"Funaoka, Y. et al. Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91. J Virol 85, 5986\u20135994 (2011).","journal-title":"J Virol"},{"key":"BFsrep00637_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jhep.2008.12.021","volume":"50","author":"KA Kim","year":"2009","unstructured":"Kim, K. A. et al. Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV\/HIV infection. J Hepatol 50, 705\u2013711 (2009).","journal-title":"J Hepatol"},{"key":"BFsrep00637_CR9","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1872-034X.2009.00529.x","volume":"39","author":"H Miyaaki","year":"2009","unstructured":"Miyaaki, H. et al. Predictive value of suppressor of cytokine signal 3 (SOCS3) in the outcome of interferon therapy in chronic hepatitis C. Hepatol Res 39, 850\u2013855 (2009).","journal-title":"Hepatol Res"},{"key":"BFsrep00637_CR10","doi-asserted-by":"publisher","first-page":"6060","DOI":"10.1128\/JVI.02484-09","volume":"84","author":"RX Shao","year":"2010","unstructured":"Shao, R. X. et al. Suppressor of cytokine signaling 3 suppresses hepatitis C virus replication in an mTOR-dependent manner. J Virol 84, 6060\u20136069 (2010).","journal-title":"J Virol"},{"key":"BFsrep00637_CR11","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1126\/science.1085242","volume":"301","author":"J Carrington","year":"2003","unstructured":"Carrington, J. & Ambros, V. Role of microRNAs in plant and animal development. Science 301, 336\u2013338 (2003).","journal-title":"Science"},{"key":"BFsrep00637_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism and function. Cell. 116, 281\u2013297 (2004).","journal-title":"Cell."},{"key":"BFsrep00637_CR13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros, V. The functions of animal microRNAs. Nature 431, 350\u2013355 (2004).","journal-title":"Nature"},{"key":"BFsrep00637_CR14","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu, J. et al. MicroRNA expression profiles classify human cancers. Nature 435, 834\u2013838 (2005).","journal-title":"Nature"},{"key":"BFsrep00637_CR15","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.bbrc.2011.07.048","volume":"411","author":"A Takata","year":"2011","unstructured":"Takata, A. et al. MicroRNA-22 and microRNA-140 suppress NF-\u03baB activity by regulating the expression of NF-\u03baB coactivators. Biochem Biophys Res Commun 411, 826\u2013831 (2011).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep00637_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nsmb.1533","volume":"16","author":"SY Park","year":"2009","unstructured":"Park, S. Y., Lee, J. H., Ha, M., Nam, J. W. & Kim, V. N. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol 16, 23\u201329 (2009).","journal-title":"Nat Struct Mol Biol"},{"key":"BFsrep00637_CR17","first-page":"147","volume":"12","author":"AL Kasinski","year":"2010","unstructured":"Kasinski, A. L. & Slack, F. J. Potential microRNA therapies targeting Ras, NFkappaB and p53 signaling. Curr Opin Mol Ther 12, 147\u2013157 (2010).","journal-title":"Curr Opin Mol Ther"},{"key":"BFsrep00637_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/jmcb\/mjr007","volume":"3","author":"X Ma","year":"2011","unstructured":"Ma, X., Becker Buscaglia, L. E., Barker, J. R. & Li, Y. MicroRNAs in NF-{kappa}B signaling. J Mol Cell Biol 3, 159\u2013166 (2011).","journal-title":"J Mol Cell Biol"},{"key":"BFsrep00637_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.1136235","volume":"315","author":"HW Hwang","year":"2007","unstructured":"Hwang, H. W., Wentzel, E. A. & Mendell, J. T. A hexanucleotide element directs microRNA nuclear import. Science 315, 97\u2013100 (2007).","journal-title":"Science"},{"key":"BFsrep00637_CR20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.molcel.2010.03.008","volume":"38","author":"L Wu","year":"2010","unstructured":"Wu, L. et al. DNA methylation mediated by a microRNA pathway. Mol Cell 38, 465\u201347 (2010).","journal-title":"Mol Cell"},{"key":"BFsrep00637_CR21","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1111\/j.1742-4658.2011.08089.x","volume":"278","author":"F Sato","year":"2011","unstructured":"Sato, F., Tsuchiya, S., Meltzer, S. J. & Shimizu, K. MicroRNAs and epigenetics. FEBS J 278, 1598\u20131609 (2011).","journal-title":"FEBS J"},{"key":"BFsrep00637_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/B978-0-12-380866-0.60004-6","volume":"70","author":"M Fabbri","year":"2010","unstructured":"Fabbri, M. & Calin, G. A. Epigenetics and miRNAs in human cancer. Adv Genet 70, 87\u201399 (2010).","journal-title":"Adv Genet"},{"key":"BFsrep00637_CR23","doi-asserted-by":"publisher","first-page":"17R","DOI":"10.1203\/pdr.0b013e318045760e","volume":"61","author":"P Saetrom","year":"2007","unstructured":"Saetrom, P., Sn\u00f8ve, O. & Rossi, J. J. Epigenetics and microRNAs. Pediatr Res 61, 17R\u201323R (2007).","journal-title":"Pediatr Res"},{"key":"BFsrep00637_CR24","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","volume":"129","author":"P Landgraf","year":"2007","unstructured":"Landgraf, P. et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401\u20131414 (2007).","journal-title":"Cell"},{"key":"BFsrep00637_CR25","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cell.2006.04.031","volume":"125","author":"S Bhattacharyya","year":"2006","unstructured":"Bhattacharyya, S., Habermacher, R., Martine, U., Closs, E. & Filipowicz, W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 125, 1111\u20131124 (2006).","journal-title":"Cell"},{"key":"BFsrep00637_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","volume":"3","author":"C Esau","year":"2006","unstructured":"Esau, C. et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3, 87\u201398 (2006).","journal-title":"Cell Metab"},{"key":"BFsrep00637_CR27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/366362a0","volume":"366","author":"E Li","year":"1993","unstructured":"Li, E., Beard, C. & Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature 366, 362\u2013365 (1993).","journal-title":"Nature"},{"key":"BFsrep00637_CR28","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1089\/jir.2005.25.733","volume":"25","author":"MM Brierley","year":"2005","unstructured":"Brierley, M. M. & Fish, E. N. Stats: multifaceted regulators of transcription. J Interferon Cytokine Res 25, 733\u2013744 (2005).","journal-title":"J Interferon Cytokine Res"},{"key":"BFsrep00637_CR29","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias, L. C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5, 375\u2013386 (2005).","journal-title":"Nat Rev Immunol"},{"key":"BFsrep00637_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1096\/fj.11-191122","volume":"26","author":"L Icardi","year":"2011","unstructured":"Icardi, L. et al. Opposed regulation of type I IFN-induced STAT3 and ISGF3 transcriptional activities by histone deacetylases (HDACS) 1 and 2. FASEB J 26, 240\u20139 (2011).","journal-title":"FASEB J"},{"key":"BFsrep00637_CR31","doi-asserted-by":"publisher","first-page":"14111","DOI":"10.1074\/jbc.M511797200","volume":"281","author":"HH Ho","year":"2006","unstructured":"Ho, H. H. & Ivashkiv, L. B. Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation. J Biol Chem 281, 14111\u201314118 (2006).","journal-title":"J Biol Chem"},{"key":"BFsrep00637_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1089\/jir.2010.0037","volume":"30","author":"MP Gantier","year":"2010","unstructured":"Gantier, M. P. New perspectives in MicroRNA regulation of innate immunity. J Interferon Cytokine Res 30, 283\u2013289 (2010).","journal-title":"J Interferon Cytokine Res"},{"key":"BFsrep00637_CR33","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1089\/jir.2010.0080","volume":"30","author":"M David","year":"2010","unstructured":"David, M. Interferons and microRNAs. J Interferon Cytokine Res 30, 825\u2013828 (2010).","journal-title":"J Interferon Cytokine Res"},{"key":"BFsrep00637_CR34","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nature04303","volume":"438","author":"J Kr\u00fctzfeldt","year":"2005","unstructured":"Kr\u00fctzfeldt, J. et al. Silencing of microRNAs in vivo with \u2018antagomirs\u2019. Nature 438, 685\u2013689 (2005).","journal-title":"Nature"},{"key":"BFsrep00637_CR35","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1101\/gad.1781009","volume":"23","author":"D Gatfield","year":"2009","unstructured":"Gatfield, D. et al. Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev 23, 1313\u20131326 (2009).","journal-title":"Genes Dev"},{"key":"BFsrep00637_CR36","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/ncomms1345","volume":"2","author":"K Kojima","year":"2011","unstructured":"Kojima, K. et al. MicroRNA122 is a key regulator of \u03b1-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. Nat Commun 2, 338 (2011).","journal-title":"Nat Commun"},{"key":"BFsrep00637_CR37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215\u2013233 (2009).","journal-title":"Cell"},{"key":"BFsrep00637_CR38","doi-asserted-by":"crossref","unstructured":"Jopling, C., Yi, M., Lancaster, A., Lemon, S. & Sarnow, P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309, (2005).","DOI":"10.1126\/science.1113329"},{"key":"BFsrep00637_CR39","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1126\/science.1178178","volume":"327","author":"RE Lanford","year":"2010","unstructured":"Lanford, R. E. et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198\u2013201 (2010).","journal-title":"Science"},{"key":"BFsrep00637_CR40","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nbt0711-553","volume":"29","author":"C Sheridan","year":"2011","unstructured":"Sheridan, C. New Merck and Vertex drugs raise standard of care in hepatitis C. Nat Biotechnol 29, 553\u2013554 (2011).","journal-title":"Nat Biotechnol"},{"key":"BFsrep00637_CR41","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nature06205","volume":"449","author":"IM Pedersen","year":"2007","unstructured":"Pedersen, I. M. et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449, 919\u2013922 (2007).","journal-title":"Nature"},{"key":"BFsrep00637_CR42","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/ng.447","volume":"41","author":"V Suppiah","year":"2009","unstructured":"Suppiah, V. et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41, 1100\u20131104 (2009).","journal-title":"Nat Genet"},{"key":"BFsrep00637_CR43","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/ng.449","volume":"41","author":"Y Tanaka","year":"2009","unstructured":"Tanaka, Y. et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41, 1105\u20131109 (2009).","journal-title":"Nat Genet"},{"key":"BFsrep00637_CR44","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.tcb.2006.12.007","volume":"17","author":"RS Pillai","year":"2007","unstructured":"Pillai, R. S., Bhattacharyya, S. N. & Filipowicz, W. Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol. 17, 118\u2013126 (2007).","journal-title":"Trends Cell Biol."},{"key":"BFsrep00637_CR45","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1053\/j.gastro.2010.04.049","volume":"139","author":"M Honda","year":"2010","unstructured":"Honda, M. et al. Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology 139, 499\u2013509 (2010).","journal-title":"Gastroenterology"},{"key":"BFsrep00637_CR46","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1002\/jmv.20979","volume":"79","author":"N Akuta","year":"2007","unstructured":"Akuta, N. et al. Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b. J Med Virol 79, 1686\u20131695 (2007).","journal-title":"J Med Virol"},{"key":"BFsrep00637_CR47","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/jmv.21202","volume":"80","author":"N Akuta","year":"2008","unstructured":"Akuta, N. et al. Substitution of amino acid 70 in the hepatitis C virus core region of genotype 1b is an important predictor of elevated alpha-fetoprotein in patients without hepatocellular carcinoma. J Med Virol 80, 1354\u20131362 (2008).","journal-title":"J Med Virol"},{"key":"BFsrep00637_CR48","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/hep.22176","volume":"47","author":"N Dharel","year":"2008","unstructured":"Dharel, N. et al. Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus. Hepatology 47, 1136\u20131149 (2008).","journal-title":"Hepatology"},{"key":"BFsrep00637_CR49","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.immuni.2007.05.014","volume":"27","author":"M Otsuka","year":"2007","unstructured":"Otsuka, M. et al. Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 27, 123\u2013134 (2007).","journal-title":"Immunity"},{"key":"BFsrep00637_CR50","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1172\/JCI33680","volume":"118","author":"M Otsuka","year":"2008","unstructured":"Otsuka, M. et al. Impaired microRNA processing causes corpus luteum insufficiency and infertility in mice. J Clin Invest 118, 1944\u20131954 (2008).","journal-title":"J Clin Invest"},{"key":"BFsrep00637_CR51","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2217\/epi.09.14","volume":"1","author":"M Bibikova","year":"2009","unstructured":"Bibikova, M. et al. Genome-wide DNA methylation profiling using Infinium assay. Epigenomics 1, 177\u2013200 (2009).","journal-title":"Epigenomics"},{"key":"BFsrep00637_CR52","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/bioinformatics\/18.11.1427","volume":"18","author":"LC Li","year":"2002","unstructured":"Li, L. C. & Dahiya, R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 18, 1427\u20131431 (2002).","journal-title":"Bioinformatics"},{"key":"BFsrep00637_CR53","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.1093\/nar\/17.15.6419","volume":"17","author":"E Schreiber","year":"1989","unstructured":"Schreiber, E., Matthias, P., M\u00fcller, M. & Schaffner, W. Rapid detection of octamer binding proteins with \u2018mini-extracts\u2019, prepared from a small number of cells. Nucleic Acids Res 17, 6419 (1989).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep00637_CR54","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.4049\/jimmunol.160.11.5475","volume":"160","author":"LH Wong","year":"1998","unstructured":"Wong, L. H., Hatzinisiriou, I., Devenish, R. J. & Ralph, S. J. IFN-gamma priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type I IFNs. J Immunol 160, 5475\u20135484 (1998).","journal-title":"J Immunol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep00637","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep00637.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep00637.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T04:26:05Z","timestamp":1672979165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep00637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,6]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,12,21]]}},"alternative-id":["BFsrep00637"],"URL":"https:\/\/doi.org\/10.1038\/srep00637","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,6]]},"assertion":[{"value":"25 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"637"}}